Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Perren

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|February 7, 2013
Targeted anti-vascular therapies for ovarian cancer: current evidenceM Hall, C Gourley, I McNeish, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's diseaseM Harding, P Selby, M Gore, et al.
British Journal of Cancer|August 1, 1990
ChlVPP combination chemotherapy for Hodgkin's disease: long-term resultsP Selby, P Patel, S Milan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposideM Gore, R Powles, A Lakhani, et al.
BMJ (Clinical Research Ed.)|March 12, 1994
Management of breast cancer. Refer women to multidisciplinary breast clinicsJ R Yarnold, J M Bliss, M Brunt, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2016
Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatmentH Fatayer, N Sharma, D Manuel, et al.
Bone Marrow Transplantation|January 1, 1988
Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remissionG Helenglass, R L Powles, T J McElwain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnairesG Velikova, E P Wright, A B Smith, et al.
European Journal of Gynaecological Oncology|July 30, 2011
A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesisS R Muthuramalingam, J P Braybrooke, A D Blann, et al.
British Journal of Cancer|July 9, 2004
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancerM Harries, C Moss, T Perren, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|February 7, 2013
Targeted anti-vascular therapies for ovarian cancer: current evidenceM Hall, C Gourley, I McNeish, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's diseaseM Harding, P Selby, M Gore, et al.
British Journal of Cancer|August 1, 1990
ChlVPP combination chemotherapy for Hodgkin's disease: long-term resultsP Selby, P Patel, S Milan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposideM Gore, R Powles, A Lakhani, et al.
BMJ (Clinical Research Ed.)|March 12, 1994
Management of breast cancer. Refer women to multidisciplinary breast clinicsJ R Yarnold, J M Bliss, M Brunt, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2016
Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatmentH Fatayer, N Sharma, D Manuel, et al.
Bone Marrow Transplantation|January 1, 1988
Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remissionG Helenglass, R L Powles, T J McElwain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnairesG Velikova, E P Wright, A B Smith, et al.
European Journal of Gynaecological Oncology|July 30, 2011
A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesisS R Muthuramalingam, J P Braybrooke, A D Blann, et al.
British Journal of Cancer|July 9, 2004
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancerM Harries, C Moss, T Perren, et al.
Pageof 4